(Q38507121)

3 September 2017

title

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells (English)

1 reference

3 September 2017

main subject

myelodysplastic syndrome

1 reference

A Pellagatti

1

0 references

Jacqueline Boultwood

object named as

J Boultwood

13

0 references

author name string

M Cazzola

2

1 reference

3 September 2017

A Giagounidis

3

1 reference

3 September 2017

J Perry

4

1 reference

3 September 2017

L Malcovati

5

1 reference

3 September 2017

M G Della Porta

6

1 reference

3 September 2017

M Jädersten

7

1 reference

3 September 2017

S Killick

8

1 reference

3 September 2017

A Verma

9

1 reference

3 September 2017

C J Norbury

10

1 reference

3 September 2017

E Hellström-Lindberg

11

1 reference

3 September 2017

J S Wainscoat

12

1 reference

3 September 2017

publication date

11 March 2010

1 reference

3 September 2017

1 reference

3 September 2017

volume

24

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

756-764

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.31

3 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Evolving classifications of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

The cytogenetics of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Distinct haematological disorder with deletion of long arm of no. 5 chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Acquired mutations in TET2 are common in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Myelodysplastic syndromes: biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Insights into signaling and function of hematopoietic stem cells at the single-cell level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

The role of the immune system in myelodysplasia: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Chk1 is haploinsufficient for multiple functions critical to tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Molecular views of recombination proteins and their control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Fanconi anaemia and leukaemia - clinical and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Protective role for c-Jun in the cellular response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

The role of CREB as a proto-oncogene in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Chromosome and molecular abnormalities in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Pathobiology, classification, and diagnosis of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Ceramide-induced cell death in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Therapeutic potential of "rexinoids" in cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

Myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Gene expression profiling of CD34+cells in patients with the 5q− syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.31

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.31

1 reference

Dimensions Publication ID

3 September 2017

1015392938

0 references

1 reference